DALRYMPLE & ASSOCIATES, LLC for CRUCELL, NA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE New | Principal |
Homeland Security HOM
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE New | Principal |
Medical/Disease Research/Clinical Labs MED
Infectious Disease and Biodefense Vaccine & Therapeutic Product R&D and acquisition funded by HHS, NIAID, CDC, DOD, DTRA, JPOCBD and related authorization and appropriations legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE New | Principal |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CRUCELL NA | Netherlands | Netherlands | 100.0% | $60,000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.